Prostate Cancer

LSD1 promotes prostate cancer cell reprogramming through TP53 repression

Genomic sequencing fine-tunes prostate cancer diagnosis

9 February 2023

New blood test for prostate cancer shows 94% accuracy

19 September 2022

Why do some prostate cancer drugs fail?

8 September 2022

Epitranscriptome biomarkers successfully distinguish early and late-stage prostate cancer

5 September 2022

New genomics study describes African-specific mutational profiles in prostate cancer

New research precisely maps genetic mutations onto malignant and benign prostate tissue

Overcoming enzalutamide drug resistance in prostate cancer

Bacteria Linked to Prostate Cancer Could Be a New Disease Biomarker

Clinical and Genomic Profiles of Black Patients with Prostate Cancer